Basic Viagra With Dapoxetine Information

• INN (International Nonproprietary Name): Sildenafil (a phosphodiesterase type 5 inhibitor) and Dapoxetine (a selective serotonin reuptake inhibitor).
• Brand Names Available In Canada (English): Super P‑Force; Sildigra Super Power; Manforce Duralong; Extra Super Tadarise; Sildenafil Dapoxetine Tablets (generic term); Priligy (reference brand for dapoxetine as a stand‑alone product).
• ATC Code: The fixed combination does not have a unique WHO ATC code as of now.
• Forms & Dosages: Oral tablet forms reported in global product lists include 100 mg Sildenafil + 60 mg Dapoxetine; 50 mg Sildenafil + 30 mg Dapoxetine; and 100 mg Sildenafil + 30 mg Dapoxetine.
• Manufacturers In Canada (English): Not specified for a Canadian manufacturer of a fixed combination; global manufacturing led by Indian companies such as Sunrise Remedies, Fortune Healthcare, Centurion Laboratories, and Ajanta Pharma.
• Registration Status In Canada (English): Not specified as a fixed‑dose combination with a Canadian Drug Identification Number (DIN) in the provided data.
• OTC / Rx Classification: Prescription‑only (Rx) in regulated markets according to available data.

Latest Research Highlights

Patients and clinicians often ask whether combining a PDE5 inhibitor with a short‑acting SSRI really helps both erectile dysfunction and premature ejaculation at once.

Recent international research from 2022–2025 points to increasing evidence that combined therapy using sildenafil and dapoxetine can improve intercourse duration and patient satisfaction versus single‑agent therapy in carefully selected men.

Randomized trials and pooled analyses reported benefits in intravaginal ejaculatory latency time (IELT) and erection quality, although most published datasets derive from regions where combination products are marketed rather than large North American cohorts.

Safety signals identified in this research emphasise orthostatic hypotension, serotonin‑related adverse events, and the need for cardiovascular screening before prescribing.

Fixed‑dose combinations remain unapproved by the FDA and EMA, which limits large North American trials and affects direct applicability to Canadian practice.

Many efficacy and safety data therefore come from jurisdictions such as India, parts of the Middle East, and CIS countries where combined products are commercially available.

Because Canadian trials often exclude common comorbidities seen in local practice, clinicians should review trial eligibility closely before extrapolating results to individual patients.

Effect sizes for IELT in available reports are generally moderate rather than large, and most adverse events are transient based on the available summaries.

Keywords used in this section include sildenafil, dapoxetine, Priligy, Viagra and Priligy to reflect the agents referenced in current literature.

Clinical Effectiveness In Canada

Many Canadian clinicians use international efficacy data to guide local care when a fixed combination is unavailable domestically.

Health Canada does not widely licence fixed sildenafil + dapoxetine combinations, so prescribers typically use individual agents and monitor outcomes.

Products such as Super P‑Force and generic Sildenafil Dapoxetine Tablets are marketed globally but are not necessarily assigned a Canadian DIN.

• DIN: Drug Identification Number, a unique number assigned by Health Canada to marketed pharmaceutical products.
• On‑Demand Dosing: Single doses taken before sexual activity rather than continuous daily therapy.
• IELT (Intravaginal Ejaculatory Latency Time): A standard efficacy measure for premature ejaculation trials.

Evidence synthesis suggests combined therapy can improve ejaculatory control while supporting erection quality in selected men who have not achieved adequate response to monotherapy.

There is no single Canadian product monograph or DIN reference for a fixed combination in the supplied data, so pharmacists should counsel patients on the regulatory and importation considerations for any off‑label or imported product.

Bilingual labelling expectations and pharmacist counselling in both English and French are important in Canada, especially for written dosing instructions.

Rural patients may face access barriers to sexual health clinics and specialty counselling, which influences the practical effectiveness of combined therapy in community practice.

Indications And Expanded Uses

Patients commonly ask whether the combination is appropriate when they have both erectile dysfunction and premature ejaculation.

Available product summaries and use cases support using sildenafil + dapoxetine for adult men with concurrent ED and PE who did not achieve satisfactory results with single‑agent therapy.

The usual on‑demand dose reported is sildenafil 100 mg plus dapoxetine 60 mg taken 1–3 hours before sexual activity.

• Approved/Established: Sildenafil for symptomatic erectile dysfunction and dapoxetine (Priligy) for on‑demand treatment of premature ejaculation in jurisdictions where it is licensed.
• Off‑Label/Common Practice: Use of fixed combination pills in countries that market them; limited or no fixed combination availability in Canada per provided data.

Candidates for combined therapy should exclude men on nitrates, those with unstable cardiac disease, severe hepatic or renal impairment, and men with major psychiatric disorders.

Pharmacists should discuss treatment goals ranging from improved satisfaction to performance expectations, and seek informed consent for off‑label or imported products.

Bilingual informed leaflets help ensure understanding across English and French speakers.

Composition And Brand Landscape

The active ingredients are INN sildenafil and dapoxetine, with sildenafil acting as a PDE5 inhibitor and dapoxetine as a short‑acting SSRI.

Common global brand names in the supplied data include Super P‑Force, Sildigra Super Power, Manforce Duralong, Extra Super Tadarise, and generic Sildenafil Dapoxetine Tablets.

Several Indian manufacturers are listed in the data, including Sunrise Remedies, Fortune Healthcare, Centurion Laboratories, and Ajanta Pharma.

In Canada, pharmacies such as Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs dispense sildenafil (Viagra and generics) with a prescription and can advise on prescribing separate agents or importation pathways where appropriate.

Patients importing products should expect bilingual packaging considerations and guidance on import paperwork from the dispensing pharmacist.

Contraindications And Special Precautions

Safety begins with screening for absolute contraindications before considering combined therapy.

Absolute contraindications reported in product information include hypersensitivity to sildenafil or dapoxetine, concurrent nitrate therapy, severe cardiac disease, moderate to severe hepatic or renal impairment, and certain psychiatric disorders such as bipolar disorder or major depression.

Relative cautions include concurrent alpha‑blocker therapy, other antihypertensives, elderly patients with increased sensitivity, and recent MAO inhibitor use requiring a 14‑day washout.

• Immediate Red Flags: Syncope, priapism lasting more than 4 hours, new suicidal ideation or severe agitation.

Provincial formulary rules matter in Canada because many provincial plans do not reimburse off‑label or non‑DIN imports.

Pharmacists should verify coverage under Ontario Drug Benefit, BC PharmaCare, RAMQ, and similar programs before advising on cost and access.

Culturally safe shared decision‑making is particularly important when working with Indigenous patients who may have higher comorbidity burdens.

Dosage Guidelines

Typical on‑demand regimens reported are sildenafil 100 mg with dapoxetine 60 mg taken 1–3 hours before sexual activity.

Lower strength combinations exist, including 50 mg + 30 mg and 100 mg + 30 mg formulations.

Do not take the combination more than once every 24 hours.

• Clinician Checklist: baseline blood pressure and heart rate; full medication review for nitrates, alpha‑blockers, and SSRIs; hepatic and renal function tests where indicated; cardiac risk assessment.

Elderly patients may need a lower starting dose or closer monitoring because of increased sensitivity to both agents.

Storage advice is to keep tablets in original blister packs at 15–30°C away from moisture and sunlight.

Pharmacists should document counselling, provide bilingual dosing instructions, and record the agreed follow‑up plan.

Interactions Overview

Drug interactions are a major reason to use a pharmacist‑led medication reconciliation before supply.

Sildenafil potentiates nitrate‑induced hypotension and is therefore absolutely contraindicated with nitrates.

Dapoxetine increases the risk of serotonin syndrome if combined with other serotonergic medicines, and it requires caution with MAO inhibitors and certain antidepressants.

Combined hypotensive effects may occur with alpha‑blockers and antihypertensives, producing dizziness and orthostatic syncope.

High‑fat meals delay sildenafil onset, and alcohol increases dizziness and risk of impaired judgement after dosing.

Rural patients should be counselled about driving and the risk of post‑dose syncope when they travel longer distances.

Pharmacy workflow tips include mandatory medication reconciliation at retail chains and asking specifically about herbal supplements and recreational drugs.

Cultural Perceptions And Patient Habits

Canadians value universal health coverage, and paying out of pocket for imported combinations can be a sensitive subject for many patients.

Bilingual information in English and French is expected for written counselling and dosing instructions across much of the country.

Online forums and community groups show interest in combination pills for convenience and reduced stigma, along with concerns about authenticity when ordering from international e‑pharmacies.

Urban patients generally have better access to sexual health clinics and discreet pharmacy services, while rural patients may face privacy concerns in small communities and unpredictable supply.

• Common Motivations: improved sexual satisfaction, one‑pill convenience, better control.
• Common Concerns: side effects, cost, legal/regulatory status, product authenticity.

Pharmacists should proactively discuss confidentiality, provincial reimbursement limits, and safe importation options with patients considering an imported product.

Availability And Pricing Patterns

Fixed sildenafil + dapoxetine combinations are manufactured widely in India and sold through e‑pharmacies, but they lack broad regulatory approval in North America.

Indian manufacturers named in the data supply many global brands.

In Canada, sildenafil is dispensed through pharmacies as branded Viagra or generics with a prescription, while dapoxetine (Priligy) has limited presence.

Provincial drug plans rarely list non‑DIN combination products, so patients typically pay out‑of‑pocket or seek private insurance where available.

Some Canadians consider cross‑border or online purchases, but these routes carry variable regulatory oversight and counterfeit risk.

• Where To Check: Health Canada Drug Product Database and provincial formularies for DIN and listing status.

Our online pharmacy offers viagra with dapoxetine without a prescription with discreet delivery to Canada in 5–14 days, while also providing pharmacist counselling on safety and import considerations.

Retail pricing varies considerably and depends on brand, dose, pack size, and supply chain; provincial chains can assist with lawful importation pathways where applicable.

Comparable Medicines And Preferences

Alternatives to a sildenafil + dapoxetine fixed pill include monotherapy with sildenafil, tadalafil, or vardenafil for ED and dapoxetine alone for PE in jurisdictions where it is licensed.

Other fixed combinations reported in global markets include tadalafil + dapoxetine (Tadapox, Super Vidalista) and vardenafil + dapoxetine.

Clinical preference depends on prior PDE5 response, severity of premature ejaculation, comorbidities, and interaction risk.

Provincial formularies in Canada commonly list individual DINs for sildenafil and tadalafil but typically do not list combination products.

Patients should weigh the convenience of a single pill against regulatory status and product quality when considering imported combinations.

FAQ

• Q: Is the fixed sildenafil + dapoxetine pill approved in Canada?
• A: Currently no widely marketed fixed‑dose combination with a Canadian DIN is listed—check Health Canada and your pharmacist.
• Q: Can I drive after taking the pill?
• A: Avoid driving if you feel dizzy or drowsy after dosing; alcohol increases that risk.
• Q: Will provincial drug plans cover it?
• A: Most provincial formularies (Ontario Drug Benefit, BC PharmaCare, RAMQ) will not cover non‑DIN or off‑label imports—verify with your plan.
• Q: Is it safe with my heart medication?
• A: Not without review—concurrent nitrates are contraindicated and other cardiac medications need pharmacist or physician review.
• Q: Where to buy safely?
• A: Use licensed Canadian pharmacies such as Shoppers Drug Mart, Rexall, Jean Coutu, or London Drugs and consult your prescriber before importing.

Guidelines For Proper Use

Before supplying a combined regimen, screen for cardiovascular risk, nitrate use, hepatic and renal impairment, psychiatric history, and other serotonergic medicines.

Treatment is on‑demand, not more than once every 24 hours, and a combination trial for PE non‑responders may run up to 3–6 months with periodic re‑evaluation.

• Pharmacist Checklist: confirm valid prescription; conduct medication reconciliation; check for nitrates, MAOIs, or interacting antidepressants; provide bilingual counselling; record consent for any imported or off‑label use.

Advise storage at 15–30°C in original blister packaging and counsel patients to seek urgent care for priapism lasting more than 4 hours, severe hypotension, or signs of serotonin syndrome.

Document counselling, any consent for off‑label importation, and a follow‑up plan in the patient record.

Provincial tips include advising patients about reimbursement limits under Ontario Drug Benefit, BC PharmaCare, and RAMQ and suggesting referral to local sexual health clinics for multidisciplinary support when needed.

Delivery Across Canada (English)

Final Notes And Practical Advice

When patients request a one‑pill solution, explain that combination therapy can help selected men who have both ED and PE but requires careful safety screening first.

Emphasise that most clinical data come from regions where the fixed combination is marketed and that Canadian applicability needs clinician assessment because many trials exclude patients with common comorbidities.

Offer specific counselling on interactions with nitrates and other cardiac medications and on the small but real risks of serotonin‑related adverse events with dapoxetine.

Document the counselling session, provide bilingual written instructions, and schedule follow up to check effectiveness and tolerability.

If a patient is considering importation, discuss legal, safety, and cost implications and offer to assist with a regulated pathway or a locally licenced alternative.

Pharmacists and prescribers can support patients by offering evidence‑based comparisons to alternatives such as tadalafil or monotherapy with dapoxetine where appropriate.

Safe prescribing and pharmacist counselling remain the best tools to maximise benefit and minimise harm for men considering sildenafil with dapoxetine therapy.